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INTRODUCTION
People sometimes live in high-altitude, hypoxic environments and this requires the body to make a complex series of compensatory changes in neurohumoral regulation, involving physiological, biochemical, and morphological changes to achieve a balance between the internal and external environment. When an individual returns to the normal oxygen environment, the body undergoes a series of corresponding changes resulting in the gradual elimination of the adaptive changes previously made. Many people undergoing this process experience symptoms such as dizziness, palpitations, chest tightness, drowsiness, precordial region pain, general fatigue, and weakness. This response is termed a high altitude de-adaptation the response, HADAR [1] [2] [3] [4] [5] . In severe cases, these symptoms can seriously affect the individual's work and life; due to the severity, some people have had to return to the high-altitude environment. HADAR is a problem of great concern and research.
Following the 2010 earthquake in Yushu, Qinghai Province, China, 96 young soldiers were rapidly deployed from a low altitude environment to a plateau area (elevation 3700 -4800 m) where they engaged in heavy physical labor for 50 days, before returning to their original station (elevation 1500 m). This study was conducted to examine cardiac function, structure, and cardiac enzyme levels as part of an investigation into acute mountain sickness (acute high-altitude response; AHAR) as well as their symptoms at 12 h, 15 d, and 30 d after their return to low altitude (HADAR response symptoms). This report describes the observed relationship among the severity of HADAR, AHAR, and heart damage.
SUBJECTS AND METHODS

Subjects
Following the Yushu earthquake, 96 male soldiers (18 -35 years old; mean age 21.8 ± 3.6 years) were deployed to a high-altitude environment (3700 -4800 m) to engage in heavy, manual labor. These men were the subjects of observations made once they reached the plateau and began participating in rescue operations (loading and unloading goods, cleaning up debris, etc.) involving heavy, physical labor for 10 h per day, every day. Following their high-altitude stay of 50 d and at 12 h, 15 d, and 30 d after their return to their normal altitude environment (1500 m), their cardiac structure, function, and cardiac drive were examined. A control group (Group D) consisted of 50 soldiers who remained at the 1500 m altitude and engaged in a similar intensity of work. This control men, aged 19 -20 years old (mean age, 22.7 ± 3.2 years) were similar in age, physical condition, work intensity to the group deployed to the plateau.
Based on AHAR symptom scores, the high-altitude group was divided into a severe AHAR group (Group A, n = 24), a mild to moderate group (Group B, n = 47), and a asymptomatic group (Group C, n = 25). Upon their return to the lower elevation, these same individuals were divided into another 3 groups depending on the severity of their HADAR symptoms: severe group (Group E, n = 19), mild to moderate group (Group F, n = 40), and asymptomatic group (Group G, n = 37). The study was approved by the Third Military Medical University medical ethics committee and the 68303 forces ethics committee; all subjects voluntarily participated in the observational part of the study and provided signed informed consent.
Methods
AHAR Determination
During the high-altitude observation, the subjects were observed daily by a physician and received an AHAR score, based on our AHAR symptom scoring system [3, 6] . The subjects receiving a total of 1 -4 points were normal, 5 -10 points were considered mildly symptomatic, 11 -15 points were moderately symptomatic, and >16 points were considered severe. As a result of the scoring, 96 subjects were symptomatic for AHAR; 24 subjects were classified as severe (25.0%, Group A), 47 subjects were mild to moderate (49.0%, Group B). AHAR symptoms were not seen in 25 subjects (26.0%, Group C). To facilitate statistical analysis, subjects with mild or moderate AHAR symptoms were combined into one group (Figure 1 ).
HADAR Determination
Upon their return to low altitude, the Health Survey week congruent was used to score the HADAR symptoms among the test subjects (19) . If the total number of points was ≤5, the subjects were considered normal, 6 -15 points were considered to be indicative of a mild reaction, 16 -25 points were a moderate response, and ≥26 points indicated a severe reaction. According to the HADAR scoring results, 59 (61.5%) subjects were observed to have symptoms; 19 subjects were severe (Group E), and 40 subjects were mild to moderate (Group F). HADAR was not observed in 37 subjects (Group G) (Figure 1) . . Inspections were made with the subject in the left lateral position, with measurement taken over a 1-h period with the subject in a resting state. The pulsed Doppler sample volume involved the measurement of the steady-state heart rate, the spectrum of the mitral and aortic blood flow, and the measurement of the peak A mitral valve flow between the end of the next cardiac cycle E peak time period (a line), and the aortic ejection time (b line). The Tei index is calculated according to the formula: Tei index = (ab/b). Simpson's method was used to calculate each subject's LVEF [7] . mPAP measurements involved the determination of right ventricular ejection early time (RVPEP) and pulmonary blood flow acceleration time (AT), and was calculated according to the equation: mPAP (mmHg) = 42.1 (RVPEP/AT) -15.7 [8, 9] . RVID, RVOT, and LVID were measured according to established methods.
Determination of Cardiac Enzyme Levels
A 3 ml, early morning, fasting blood sample was obtained, allowed to clot, and centrifuged at 4˚C for 10 min (3500 rpm, centrifugal radius = 15 cm). The resulting serum was collected and frozen at −20˚C, until analyzed. The rate method was used to determine the concentrations of serum creatine kinase isoenzyme-MB (CK-MB) and lactate dehydrogenase isoenzyme-1 (LDH-1). Measurements were made using a kit purchased from Lanzhou Biochem Bio (lanzhou, China), in strict accordance with the manufacturer's instructions. An automatic biochemical analyzer (BS-400 type; Mindray Medical Instrumentation, Shenzhen, China) was used to take the measurements.
Statistical Analysis
SPSS 17.0 software (IBM, Armonk, NY, USA) was used for statistical analyses. Homogeneity of variance among the groups was determined by single factor analysis of variance and Tamhane variance analysis when heterogeneity of variance was observed. Differ-ences between 2 groups were compared using Student's t-test, and the results obtained at different times, within each group, were compared using a paired t-test. Corre-lation analysis was performed using the Pearson's linear correlation analysis. P < 0.05 was considered statistically significant.
RESULTS
Cardiac Structure, Function, and Myocardial Enzymes in Each Group
The mPAP, RVID, RVOT, RVID/LVID ratio, Tei index, CK-MB level, and LDH-1 level were significantly higher in severe AHAR group than in mild to moderate AHAR group, asymptomatic group or control group (Figure 2) . No significant differences were evident in the LVID values (Figure 1) .
LVEF was significantly lower among severe AHAR group individuals than among those in mild to moderate AHAR group, asymptomatic group or control group. There was also a significant difference between mild to moderate AHAR group and asymptomatic group and control group; asymptomatic group was also significantly different from control group (P < 0.01) (Figure 2 ).
Relationship between AHAR with HADAR
Among the 96 subjects observed, 59 demonstrated HADAR symptoms upon returning to the lower altitude. Among the 24 subjects with severe AHAR, 18 experienced severe HADAR (75.0%), 5 (20.8%) experienced light to moderate HADAR, and 1 (4.2%) did not experience HADAR symptoms. Of the 47 subjects who suffering from mild to moderate AHAR, 1 (2.1%) experienced severe HADAR symptoms, 32 (68.1%) experienced mild to moderate HADAR, and 14 (29.8%) did not experience HADAR. Of the 25 subjects not suffering from AHAR, the HADAR was mild to moderate in 3 individuals and did not occur in 22 (88.0%) subjects. A linear correlation analysis revealed that the total AHAR points and the total HADAR points exhibited a significant positive correlation (r = 0.863, P < 0.001).
Relationship between HADAR Severity and Cardiac Structure, Function, and Cardiac Enzyme Levels after Returning to a Lower Altitude
Upon returning to a lower altitude for 12 h, Group E individuals demonstrated mPAP, RVID, RVOT, RVID/ LVID ratio, Tei index, CK-MB levels, and LDH-1 levels that were significantly higher than those for subjects in mild to moderate Group, asymptomatic group, and control group. LVEF was significantly lower in severe HADAR Group individuals than in individuals from mild to moderate HADAR Group, asymptomatic group, and control group; mild to moderate Group, asymptomatic group, and control group also demonstrated significant differences (P < 0.01). There were no significant differences in LVID between the groups (Figure 3) .
After 15 d at low altitude, severe HADAR Group mPAP, RVID, RVOT, and RVID/LVID ratios were significantly higher than in mild to moderate HADAR Group, asymp-tomatic group, and control group (P < 0.05); there was also a significant difference between mild to moderate HADAR Group individuals and those in asymptomatic group and control group (P < 0.05), but not between as-ymptomatic group and control group. The LVEF, Tei index, CK-MB levels, and LDH-1 levels in each group did not demonstrate a significant difference (P > 0.05). All data are shown in Figure 4 .
After returning to a lower altitude for 30 days, there were no significant differences among the indicators for any of the groups ( Figure 5 ). The diameter of pulmonary artery and the right ventricular outflow tract in the plateau at fiftieth days was significantly larger than the diameter of pulmonary artery and the right ventricular outflow tract in 30 days after returned to lower altitude, furthermore, compared with 50 days the exposure to high altitude, the diameter of right ventricular outflow tract was significantly larger than the diameter of pulmonary artery in 30 days after returned to lower altitude, suggesting that the right ventricular recovery than pulmonary artery slower recovery (Figure 6 ).
DISCUSSION
The results of this study showed that the right ventricular function, structure, myocardial enzyme level were significantly increased in the subjects with severe AHAR. In contrast, the left ventricular function was significantly lower. The responses of the human body to the high-altitude hypoxic environment and heavy physical work included more severe AHAR, pulmonary hypertension, changes in the right ventricle, reduced cardiac function and myocardial damage; but the changes in the left ventricular structure were less obvious. The reason may be that people engaged in heavy labor, in high-altitude, hypoxic environments, require a substantial increase in oxygen consumption. Therefore, when the body is exposed to a hypoxic environment, the hypoxia causes pulmonary vasoconstriction, pulmonary hypertension, and right ventricular load increase, leading to right ventricular enlargement. The AHAR severity, mPAP level, and right ventricular size may be related to differences in individual tolerances and responses to hypoxia. In people with poor hypoxia tolerance, hypoxic mitochondrial ATP synthesis impairment in myocardial cells may result in a reduced myocardial energy supply, leading to obvious, severe symptoms. When hypoxia tolerance is relatively good, the inhibition of mitochondrial ATP synthesis is relatively mild, resulting in relatively mild heart damage and other symptoms [10] [11] [12] [13] . For individuals who do not demonstrate AHAR, only sub-clinical effects on cardiac structure and function may occur. The results of this study also show that the total AHAR and HADAR points showed a significant positive correlation. Upon returning to the lower altitude, subjects in the severe HADAR group demonstrated mPAP, RVID, RVOT, RVID/LVID ratio, Tei index, CK-MB level, and LDH-1 level results that were significantly higher than among those in the other groups; LVEF was significantly lower than in the other groups. Among subjects in the mild to moderate HADAR group there were also similar differences between these individuals and those in the asymptomatic and control groups. After returning to a lower elevation for 15 d, individuals in the severe HA-DAR group continued to demonstrate mPAP, RVID, RVOT, and RVID/LVID ratio results that were significantly higher than those in the mild to moderate HADAR group, the asymptomatic HADAR group, or the control group. Subjects in the mild to moderate HADAR group also demonstrated significant differences in these parameters as compared with subjects in the asymptomatic HADAR group or in the control group. However, there were no differences between the HADAR group and the control group. The LVEF, Tei index, CK-MB level, and LDH-1 level values were restored to the values observed in the control group level after being at the low altitude for 30 days, The HADAR and AHAR severities were correlated with the degree of heart damage in these subjects. Those experiencing more severe AHAR while at the elevated elevation and having more significant HADAR symptoms upon their return to the low altitude experienced more severe structural damage to the right side of their hearts and a slower recovery time. After a period of adaptation to high-altitude, hypoxic environments, the return to lowaltitude environments results in hypoxia-reoxygenation injuries. The mechanism may involve the following components. 1) Energy metabolism: enhanced myocardial tissue hypoxia results in anaerobic glycolysis and decreased ATP generation, resulting in a decrease in cellular energy supply. Hypoxic damage to the mitochondria may result in the mitochondria not being effective when aerobic conditions are restored to the myocardial cells [9] . 2) Reactive oxygen species generation: oxygen free radicals (OFR) involved in clearing tissue hypoxia may result in the generation of reactive oxygen species; restoration of oxygen may result in the generation of a large number of OFR in the membranes of myocardial cells, resulting in the formation of lipid peroxides that react with intracellular proteins and nucleic acids. These peroxides may cause structural and func-tional changes to cells, leading to myocardial cell damage [14] . Zhang K, et al. [15] study confirmed, with enhanced of myocardial injuries, the increased levels of Malondialdehyde (MDA), lactate dehydrogenase (LDH) and interleukin 6 (IL-6), the LOB (Chrysoeriol7-O-[-D-glucuronopyran-osyl-(1 → 2)-O-D-glucuronopyranoside]) can decreased plasma levels of MDA, LDH, IL-6, suggesting that the LOB could be a potential therapeutic agent for myocardial ischemia/reperfusion (I/R) injury and hypoxia/reoxygenation (H/R) injury. 3) Calcium overload: anaerobic glycolysis may enhance myocardial hypoxia, causing intracellular acidosis. As the extracellular pH gradually returns to normal after the restoration of normal oxygenation, intracellular and extracellular formation of transmembrane pH gradients may result in enhanced sodium and hydrogen exchange, increasing the intracellular Na concentration. Since the cells generate less ATP after reoxygenation, the cell membrane and sarcoplasmic reticulum calcium and sodium pump functions may be reduced, leading to intracellular calcium overload. The increase in the intracellular calcium concentration can further activate endothelial cells, promoting OFR generation, and leading to further damage [16, 17] . But Li Q [18] study shows that endocannabinoids can suppresses calcium overload through inhibition of INCX during perfusion with simulated ischemic solution; the effects may be mediated by CB2 receptor via PTX-sensitive Gi/o proteins. 4) High altitude hypoxia stress induced myocardial injury, restore oxygen after myocardial injury has not been fully restored, or restore later than other functions. Hu J, et al. [19] study show that simple plateau hypoxia exposure endothelin (ET)-1 α concentrations gradually increased whereas HIF-1 expression in myocardial cells was significantly higher (P < 0.01). There was low pressure hypoxia exposure after myocardial mitochondria numbers were reduced during the initial phase of acute stress response to hypoxia and cellular injury but, later, mitochondrial numbers were restored to normal values. Plasma VEGF concentrations increased under exposure group hypoxia in low pressure hypoxia exposure, which were significantly higher than those of control group. Therefore Hu concluded that high-altitude hypoxia exposure: a) induced HIF-1 α expression; b) prompted adaptation/acclimatization after initial stress and cellular injury; and c) enhanced VEGF expression. The mechanism of HADAR and hypoxiareoxygenation injury on the body is extremely complex and requires further in-depth studies in order to more fully elucidate them.
